Literature DB >> 32394161

Insufficient glucocorticoid receptor signaling and flattened salivary cortisol profile are associated with metabolic and inflammatory indices in type 2 diabetes.

C Panagiotou1, V Lambadiari2, E Maratou1, C Geromeriati1, A Artemiadis3, G Dimitriadis2, P Moutsatsou4.   

Abstract

PURPOSE: Impaired negative feedback and hyperactivation of the hypothalamic-pituitary-adrenal (HPA) axis characterizes type 2 diabetes mellitus (T2DM). The glucocorticoid receptor (GR) is a key mediator of HPA axis negative feedback; however, its role in linking hypercortisolemia and T2DM-associated hyperglycemia, hyperlipidemia and inflammation is not yet known.
METHODS: In peripheral mononuclear cells (PBMC) from 31 T2DM patients and 24 healthy controls, we measured various GR-signaling parameters such as phosphorylated GR (pGR-S211), GRα/GRβ gene expression and GC-sensitivity [using the basal and dexamethasone (DEX)-induced leucine zipper (GILZ) and FK506 binding-protein (FKBP5) mRNA levels as well as the basal interleukin (IL)-1β protein levels]. Diurnal salivary cortisol curve parameters such as the cortisol awaking response (CAR) and area under the curve (AUCtotal and AUCi) as well as inflammatory and metabolic indices were also determined.
RESULTS: T2DM patients exhibited diminished pGR-S211 protein content, increased GRβ, decreased basal GILZ and FKBP5 mRNA levels and increased IL-1β levels. Flattened DEX-induced GILZ and FKBP5 response curves and a flattened salivary cortisol profile characterized T2DM patients. Significant associations of GR measures and saliva cortisol curve parameters with biochemical and clinical characteristics were found.
CONCLUSION: Our novel data implicate an insufficient GR signaling in PBMCs in T2DM patients and HPA axis dysfunction. The significant associations of GR-signaling parameters with inflammatory and metabolic indices implicate that GR may be the critical link between HPA axis dysfunction, hypercortisolemia and diabetes-associated metabolic disturbances. Our findings provide significant insights into the contribution of GR-mediated mechanisms in T2DM aetiopathology and therapy.

Entities:  

Keywords:  Glucocorticoid receptor; Glucocorticoid sensitivity; Inflammation; Saliva cortisol; Type 2 diabetes mellitus

Year:  2020        PMID: 32394161     DOI: 10.1007/s40618-020-01260-2

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  50 in total

1.  Association of subclinical hypercortisolism with type 2 diabetes mellitus: a case-control study in hospitalized patients.

Authors:  Iacopo Chiodini; Massimo Torlontano; Alfredo Scillitani; Maura Arosio; Simonetta Bacci; Sergio Di Lembo; Paolo Epaminonda; Giovanni Augello; Riccardo Enrini; Bruno Ambrosi; Guido Adda; Vincenzo Trischitta
Journal:  Eur J Endocrinol       Date:  2005-12       Impact factor: 6.664

2.  Hyperactivity of the hypothalamic-pituitary-adrenal axis in patients with type 2 diabetes and relations with insulin resistance and chronic complications.

Authors:  Ivana Prpić-Križevac; Silvija Canecki-Varžić; Ines Bilić-Ćurčić
Journal:  Wien Klin Wochenschr       Date:  2012-06-26       Impact factor: 1.704

3.  Cortisol secretion in patients with type 2 diabetes: relationship with chronic complications.

Authors:  Iacopo Chiodini; Guido Adda; Alfredo Scillitani; Francesca Coletti; Valentina Morelli; Sergio Di Lembo; Paolo Epaminonda; Benedetta Masserini; Paolo Beck-Peccoz; Emanuela Orsi; Bruno Ambrosi; Maura Arosio
Journal:  Diabetes Care       Date:  2007-01       Impact factor: 19.112

4.  Diurnal salivary cortisol and urinary catecholamines are associated with diabetes mellitus: the Multi-Ethnic Study of Atherosclerosis.

Authors:  Shivam Champaneri; Xiaoqiang Xu; Mercedes R Carnethon; Alain G Bertoni; Teresa Seeman; Ana Diez Roux; Sherita Hill Golden
Journal:  Metabolism       Date:  2011-12-29       Impact factor: 8.694

Review 5.  Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future.

Authors:  Steven E Kahn; Mark E Cooper; Stefano Del Prato
Journal:  Lancet       Date:  2013-12-03       Impact factor: 79.321

6.  Hypothalamic-pituitary-adrenal axis dysregulation among diabetic outpatients.

Authors:  M Roy; B Collier; A Roy
Journal:  Psychiatry Res       Date:  1990-01       Impact factor: 3.222

Review 7.  Cortisol dysregulation: the bidirectional link between stress, depression, and type 2 diabetes mellitus.

Authors:  Joshua J Joseph; Sherita H Golden
Journal:  Ann N Y Acad Sci       Date:  2016-10-17       Impact factor: 5.691

8.  Occult Cushing's syndrome in type-2 diabetes.

Authors:  Bogdan Catargi; Vincent Rigalleau; Agathe Poussin; Nathalie Ronci-Chaix; Veronique Bex; Vincent Vergnot; Henri Gin; Patrick Roger; Antoine Tabarin
Journal:  J Clin Endocrinol Metab       Date:  2003-12       Impact factor: 5.958

9.  Hypothalamic-pituitary-adrenal axis dysregulation and memory impairments in type 2 diabetes.

Authors:  Hannah Bruehl; Melanie Rueger; Isabel Dziobek; Victoria Sweat; Aziz Tirsi; Elizabeth Javier; Alyssa Arentoft; Oliver T Wolf; Antonio Convit
Journal:  J Clin Endocrinol Metab       Date:  2007-04-10       Impact factor: 5.958

10.  A blunted cortisol awakening response and hippocampal atrophy in type 2 diabetes mellitus.

Authors:  Hannah Bruehl; Oliver T Wolf; Antonio Convit
Journal:  Psychoneuroendocrinology       Date:  2009-01-24       Impact factor: 4.905

View more
  2 in total

1.  Interleukin-1 Beta in Peripheral Blood Mononuclear Cell Lysates as a Longitudinal Biomarker of Response to Antidepressants: A Pilot Study.

Authors:  Panagiotis Ferentinos; Eirini Maratou; Anastasia Antoniou; Alessandro Serretti; Nikolaos Smyrnis; Paraskevi Moutsatsou
Journal:  Front Psychiatry       Date:  2021-12-24       Impact factor: 4.157

Review 2.  Glucocorticoid Receptor Signaling in Diabetes.

Authors:  Ioanna Kokkinopoulou; Andriana Diakoumi; Paraskevi Moutsatsou
Journal:  Int J Mol Sci       Date:  2021-10-16       Impact factor: 6.208

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.